First COVID-19 vaccine tested in US poised for final testing


Team Udayavani, Jul 15, 2020, 10:50 AM IST

Washington: The first COVID-19 vaccine tested in the U.S. revved up people’s immune systems just the way scientists had hoped, researchers reported Tuesday as the shots are poised to begin key final testing.

“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert, told The Associated Press.

The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.

But Tuesday, researchers reported anxiously awaited findings from the first 45 volunteers who rolled up their sleeves back in March. Sure enough, the vaccine provided a hoped-for immune boost.

Those early volunteers developed what are called neutralizing antibodies in their bloodstream molecules key to blocking infection at levels comparable to those found in people who survived COVID-19, the research team reported in the New England Journal of Medicine.

“This is an essential building block that is needed to move forward with the trials that could actually determine whether the vaccine does protect against infection,” said Dr. Lisa Jackson of the Kaiser Permanente Washington Research Institute in Seattle, who led the study.

There’s no guarantee but the government hopes to have results around the end of the year – record-setting speed for developing a vaccine.

The vaccine requires two doses, a month apart.

There were no serious side effects. But more than half the study participants reported flu-like reactions to the shots that aren’t uncommon with other vaccines -fatigue, headache, chills, fever and pain at the injection site. For three participants given the highest dose, those reactions were more severe; that dose isn’t being pursued.

Some of those reactions are similar to coronavirus symptoms but they’re temporary, lasting about a day and occur right after vaccination, researchers noted.

“Small price to pay for protection against COVID,” said Dr. William Schaffner of Vanderbilt University Medical Center, a vaccine expert who wasn’t involved with the study.

He called the early results a ‘good first step’, and is optimistic that final testing could deliver answers about whether it”s really safe and effective by the beginning of next year.

Tuesday’s results only included younger adults. The first-step testing later was expanded to include dozens of older adults, the age group most at risk from COVID-19.

Nearly two dozen possible COVID-19 vaccines are in various stages of testing around the world. Candidates from China and Britain”s Oxford University also are entering final testing stages.

The 30,000-person study will mark the world”s largest study of a potential COVID-19 vaccine so far. And the NIH-developed shot isn’t the only one set for such massive U.S. testing, crucial to spot rare side effects. The government plans similar large studies of the Oxford candidate and another by Johnson & Johnson; separately, Pfizer Inc. is planning its own huge study.

 

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

ED arrests director of Bengaluru-based real estate group on money laundering charges

Stay in forests for 15 days a month to boost morale of personnel: K’taka CM instructs officers

Political motives behind textbook revision in Karnataka: Congress leader Ramanath Rai

Begin comprehensive development of Anjanadri Hills in a month: Karnataka CM

Find land for burial grounds in 1,428 villages: Revenue Department to officers

Guj ATS detains activist Teesta Setalvad from Mumbai day after SC upholds SIT clean chit to Modi

Congress to fight 2023 K’taka polls under collective leadership, says ex-deputy CM Parameshwara


Related Articles More

Newer Omicron subvariants escape immunity provided by vaccination, previous infection: Study

Study: Mushroom extract supports clearing human papillomavirus (HPV) infections

Poliovirus in London sewage – what you need to know

COVID deaths are now barely mentioned in the media. That changes the very nature of grief

Women are at greater risk of stroke, the more miscarriages or stillbirths they’ve had

MUST WATCH

Road Mishap at Sakaleshpur : school teacher end his life

Kinnigoli Crime News

NEWS BULLETIN 23-06-2022

Indian Book Of Records By Shashank salian

Mood swings in humans


Latest Additions

ED arrests director of Bengaluru-based real estate group on money laundering charges

Stay in forests for 15 days a month to boost morale of personnel: K’taka CM instructs officers

Political turmoil in Shiv Sena a battle between truth and lie; we will win: Aaditya Thackeray

Political motives behind textbook revision in Karnataka: Congress leader Ramanath Rai

Hardik relishes captaincy, says it brings best out of him

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.